Santé & Pharma

PIU’ MEDICAL COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE

33 M

PIU’ MEDICAL INTERIM COMMUNICATION DURING THE STABILIZATION PERIOD

PIU’ MEDICAL PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN

33 M

PIU’ MEDICAL SPA

38 M

PLx Pharma Inc.

PMV Pharmaceuticals, Inc.

60 M

PNV

712 M

POD

35 M

POINT Biopharma Global Inc.

POLARITYTE, INC.

POXEL

12 M

PPD, Inc.

PPD, Inc.

PRA Health Sciences, Inc.

PREDILIFE

7,1 M

PRIM S.A

PRIM, S.A.

224 M

PRIM, S.A.

PRO DEX INC

199 M

PRO MEDEX

301 M

PROCEPT BioRobotics Corp

1,1 Md

PROCYON CORP

1,6 M

PROGENITY, INC.

PSYCHEMEDICS CORP

15 M

PTC Therapeutics, INC.

7,4 Md

PZ Cormay S.A.

41 M

Pacific Biosciences of California, INC.

477 M

Pacific Health Care Organization INC

14 M

Pacira BioSciences, Inc.

995 M

Palatin Technologies INC

25 M

Palisade Bio, INC.

328 M

Panacea Biotec Limited

33 Md

Panacea Life Sciences Holdings, INC.

711 k

Panbela Therapeutics, Inc.

54 k

Paragon 28, Inc.

Paratek Pharmaceuticals, Inc.

Pardes Biosciences, INC.

Park Dental Partners, Inc.

82 M

Pasithea Therapeutics Corp.

Passage BIO, Inc.

17 M

Patterson Companies, INC.

Paxman AB (publ)

1,1 Md

Paxman AB (publ)

1,1 Md

Peak Processing Limited

23 M

Pear Therapeutics, Inc.

Pediatrix Medical Group, Inc.

2,2 Md

Peijia Medical Ltd. - B

2,8 Md

Pelthos Therapeutics Inc.

94 M

Pennant Group, Inc.

1,4 Md

Pentixapharm Holding AG

54 M